Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098276 · ClinicalTrials.gov registry record · NA
It's WeWomen Plus Intervention for Health, Safety and Empowerment
A NA study of Violence and Violence, Domestic, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 1,265
- Enrollment target
- 1
- Study location
NCT04098276: Completed NA study of Violence and Violence, Domestic, sponsored by Johns Hopkins University.
NCT04098276 is a NA study of Violence and Violence, Domestic that has completed, run by Johns Hopkins University. The registered enrollment target is 1,265 participants, below the 4,471-participant average among 19 other Violence trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04098276, a NA study of Violence and Violence, Domestic, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,265 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the impact of adaptive technology-based intervention (online, text and phone) "weWomenPlus" on safety, mental health and empowerment of abused immigrant women.
Primary Outcome
The adapted version of the Revised Conflict Tactics Scale (CTS2; Straus, 1996) was used to measure the severity and frequency of abusive or violent acts in intimate partner relationships. The CTS2 subscales included physical aggression, injury, psychological aggression, and sexual coercion. Response categories ranged from 0=never to 4=very frequently. Total scores ranged from 0-164, with higher scores indicating greater frequency and severity of intimate partner violence experiences. Items were
Conditions Studied
Interventions
- BEHAVIORAL WeWomen Plus technology based intervention
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,265 participants |
| Start Date | 2021-01-11 |
| Est. Completion | 2024-07-29 |
| Phase | NA |
What the finished NCT04098276 record still lists
NCT04098276 is an interventional study that assigns participants to a tested intervention. Its 1,265 participants enrollment target places it among the larger protocols in the corpus, below the 4,471-participant average among 19 other Violence trials with a reported enrollment target (72% lower).
The record links to 6 conditions, with Violence appearing as the primary indexed condition, and to 1 intervention - of which WeWomen Plus technology based intervention is the first listed.
NCT04098276 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04098276 about?
NCT04098276 is a clinical study titled "It's WeWomen Plus Intervention for Health, Safety and Empowerment". This study evaluates the impact of adaptive technology-based intervention (online, text and phone) "weWomenPlus" on safety, mental health and empowerment of abused immigrant women.
What is the current status of trial NCT04098276?
This trial is currently completed. It is a NA study. The enrollment target is 1,265 participants. The study started on 2021-01-11. Estimated completion is 2024-07-29.
What conditions does trial NCT04098276 study?
This clinical trial studies the following conditions: Violence, Violence, Domestic, Violence, Physical, Violence, Sexual, Violence, Gender-Based.
What interventions are being tested in trial NCT04098276?
The interventions under investigation include: WeWomen Plus technology based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04098276?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04098276 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04098276's enrollment target sits among peer trials
1,265 5th of 19 higher than 15 of 19 other Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evidence-based Family Support Program for Parents and Children in Palestine: a Theory-based Intervention
RECRUITING · NA
-
Preventing Retaliatory Gun Violence in Violently Injured Adults
RECRUITING · NA
-
#ChopViolence/#ChopHIV
RECRUITING · NA
-
A Hospital-based Intervention for Youth Injured Through Violence
RECRUITING · NA
-
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
RECRUITING · NA
-
A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI